![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Arizona Heart Institute |
|---|---|
| Information provided by: | Arizona Heart Institute |
| ClinicalTrials.gov Identifier: | NCT00546312 |
Purpose
This study is to evaluate safety and efficacy of endovascular repair, using the Thoracic EXCLUDER Endoprosthesis, when used in the treatment of descending thoracic aortic disease as indicated by radiological testing at time of discharge, and 1, 6, 12 months and annually following implantation, and to determine the proportion of patients who experience adverse events during and after the implantation procedure, including disease-specific and overall mortality rates.
| Condition | Intervention |
|---|---|
|
Descending Thoracic Aortic Disease |
Device: Thoracic EXCLUDER Endoprosthesis |
Show Detailed Description
Eligibility
Inclusion Criteria:
Minimum 2 cm non-aneurysmal segment proximal and distal to the aneurysm.
Exclusion Criteria:
Contacts and Locations| Contact: Christopher DiMatteo, BS | 602-266-2200 ext 3624 | cdimatteo@azheart.com |
| Contact: James Williams, BS | 602-266-2200 ext 3605 | jwilliams@azheart.com |
| United States, Arizona | |
| Arizona Heart Institute | Recruiting |
| Phoenix, Arizona, United States, 85006 | |
| Principal Investigator: Edward B Diethrich, M.D. | |
| Sub-Investigator: Julio Rodriguez-Lopez, M.D. | |
| Sub-Investigator: Venkatesh Ramaiah, M.D. | |
| Sub-Investigator: Grayson Wheatley, M.D. | |
| Principal Investigator: | Edward B Diethrich, M.D. | Arizona Heart Institute |
More Information